Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implantation Of Vaginal Construct For Patients With Vaginal Aplasia
NCT05675722Phase 1Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2023
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Müllerian duct anomaly (MDA), sponsored by Wake Forest University Health Sciences. Primary endpoints: Number of Serious Adverse Events at 36 months and Quality of Life Scores at 36 months. Started Jun 2023; status: recruiting.
02
Conditions
Müllerian duct anomaly (MDA)
Beyond the preview
Go deeper on NCT05675722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05675722.